A detailed history of Simplex Trading, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 24,829 shares of DVAX stock, worth $315,824. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,829
Previous 7,042 252.58%
Holding current value
$315,824
Previous $79,000 249.37%
% of portfolio
0.01%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.05 - $11.61 $178,759 - $206,507
17,787 Added 252.58%
24,829 $276,000
Q2 2024

Jul 25, 2024

SELL
$10.73 - $12.58 $675,442 - $791,898
-62,949 Reduced 89.94%
7,042 $79,000
Q1 2024

Apr 25, 2024

BUY
$11.7 - $14.98 $818,894 - $1.05 Million
69,991 New
69,991 $868,000
Q4 2022

Feb 02, 2023

BUY
$10.27 - $13.29 $16,740 - $21,662
1,630 Added 0.94%
175,776 $1.87 Million
Q3 2022

Nov 04, 2022

BUY
$9.93 - $17.44 $606,603 - $1.07 Million
61,088 Added 54.03%
174,146 $1.82 Million
Q2 2022

Aug 03, 2022

SELL
$7.45 - $12.83 $361,868 - $623,191
-48,573 Reduced 30.05%
113,058 $1.42 Million
Q1 2022

May 02, 2022

BUY
$9.75 - $14.44 $807,846 - $1.2 Million
82,856 Added 105.18%
161,631 $1.75 Million
Q4 2021

Feb 23, 2022

SELL
$13.17 - $20.94 $93,269 - $148,297
-7,082 Reduced 8.25%
78,775 $1.11 Million
Q3 2021

Oct 28, 2021

SELL
$9.16 - $19.83 $123,660 - $267,705
-13,500 Reduced 13.59%
85,857 $878,000
Q2 2021

Aug 12, 2021

BUY
$7.25 - $10.99 $42,332 - $64,170
5,839 Added 6.24%
99,357 $978,000
Q1 2021

Apr 26, 2021

BUY
$4.57 - $11.18 $184,276 - $450,811
40,323 Added 75.8%
93,518 $0
Q4 2020

Feb 02, 2021

BUY
$3.73 - $5.6 $80,851 - $121,385
21,676 Added 68.77%
53,195 $236,000
Q3 2020

Oct 14, 2020

SELL
$4.32 - $11.7 $246,170 - $666,712
-56,984 Reduced 64.39%
31,519 $136,000
Q2 2020

Jul 13, 2020

BUY
$2.94 - $9.1 $52,508 - $162,526
17,860 Added 25.28%
88,503 $785,000
Q1 2020

Apr 29, 2020

SELL
$2.27 - $6.2 $22,838 - $62,378
-10,061 Reduced 12.47%
70,643 $249,000
Q4 2019

Feb 05, 2020

BUY
$3.46 - $6.93 $160,025 - $320,512
46,250 Added 134.24%
80,704 $461,000
Q3 2019

Oct 15, 2019

BUY
$2.69 - $4.85 $63,438 - $114,377
23,583 Added 216.93%
34,454 $123,000
Q2 2019

Jul 26, 2019

SELL
$3.65 - $7.89 $132,316 - $286,020
-36,251 Reduced 76.93%
10,871 $43,000
Q1 2019

Apr 18, 2019

SELL
$7.08 - $12.09 $259,715 - $443,497
-36,683 Reduced 43.77%
47,122 $0
Q4 2018

Jan 16, 2019

SELL
$8.14 - $13.28 $128,896 - $210,288
-15,835 Reduced 15.89%
83,805 $766,000
Q3 2018

Oct 23, 2018

BUY
$11.85 - $16.0 $1.09 Million - $1.47 Million
91,992 Added 1202.82%
99,640 $1.24 Million
Q2 2018

Jul 30, 2018

BUY
$15.15 - $20.75 $115,867 - $158,696
7,648 New
7,648 $116,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.